Prolonged survival in patients with local chronic infection after high-grade glioma treatment: Two case reports

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F22%3A00077780" target="_blank" >RIV/00159816:_____/22:00077780 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00209805:_____/22:00079093 RIV/00216224:14110/22:00127373

Výsledek na webu

<a href="https://www.frontiersin.org/articles/10.3389/fonc.2022.1073036/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fonc.2022.1073036/full</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3389/fonc.2022.1073036" target="_blank" >10.3389/fonc.2022.1073036</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Prolonged survival in patients with local chronic infection after high-grade glioma treatment: Two case reports

Popis výsledku v původním jazyce

High-grade gliomas are primary brain tumors with poor prognosis, despite surgical treatment followed by radiotherapy and concomitant chemotherapy. We present two cases of long-term survival in patients treated for high-grade glioma and concomitant prolonged bacterial wound infection. The first patient treated for glioblastoma IDH-wildtype had been without disease progression for 61 months from the first resected recurrence. Despite incomplete chemotherapy-induced myelosuppression in the second patient with anaplastic astrocytoma IDH-mutant, she died without disease relapse after 14 years from the diagnosis due to other comorbidities. We assume that the documented prolonged survival could be related to the bacterial infection.

Název v anglickém jazyce

Prolonged survival in patients with local chronic infection after high-grade glioma treatment: Two case reports

Popis výsledku anglicky

High-grade gliomas are primary brain tumors with poor prognosis, despite surgical treatment followed by radiotherapy and concomitant chemotherapy. We present two cases of long-term survival in patients treated for high-grade glioma and concomitant prolonged bacterial wound infection. The first patient treated for glioblastoma IDH-wildtype had been without disease progression for 61 months from the first resected recurrence. Despite incomplete chemotherapy-induced myelosuppression in the second patient with anaplastic astrocytoma IDH-mutant, she died without disease relapse after 14 years from the diagnosis due to other comorbidities. We assume that the documented prolonged survival could be related to the bacterial infection.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30200 - Clinical medicine

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Frontiers in Oncology

ISSN

2234-943X

e-ISSN

—

Svazek periodika

12

Číslo periodika v rámci svazku

DEC 16

Stát vydavatele periodika

CH - Švýcarská konfederace

Počet stran výsledku

7

Strana od-do

1073036

Kód UT WoS článku

000904981000001

EID výsledku v databázi Scopus

—